Document is current
Any future updates will be listed below
-
Authors
Schulze, Josefine https://orcid.org/0000-0002-5727-9343
Breckner, Amanda
Duncan, Polly
Scherer, Martin
Pohontsch, Nadine Janis
Lühmann, Dagmar
-
Funding
Funding for this research was provided by:
G-BA Innovationsfonds (01VSF16058)
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 5 October 2021
Accepted: 17 May 2022
First Online: 3 June 2022
Declarations
:
: Ethics approval was obtained from Ethics Committee of the Hamburg Medical Association on 10th September 2018 (file no. PV5846), Clinical Ethics Committee Heidelberg on 19th December 2018 (file no. S-665/2018) and Medical Association of Baden-Wuerttemberg on 13th November (file no. B-F-2018-096). All study participants gave written informed consent prior to their participation in the study.
: Not applicable.
: Polly Duncan developed and validated the Multimorbidity Treatment Burden Questionnaire. She is also an investigator for an industry-university collaboration study between the University of Bristol and Pfizer investigating the burden of lower respiratory tract infection and community acquired pneumonia in primary care. The other authors declare that they have no competing interests.
